08Feb 2025
Finerenone Improves Cardiovascular Outcomes in Diabetes, Kidney Disease

Finerenone Improves Cardiovascular Outcomes in Diabetes, Kidney Disease

Finerenone significantly improves cardiovascular outcomes in patients with diabetes, chronic kidney disease, and heart failure. The meta-analysis of 8 trials with 21,200 patients found finerenone reduced all-cause death (RR 0.92) and major cardiovascular events (RR 0.85). Heart failure hospitalizations were also reduced (RR 0.82), although CV death showed a trend without significance (RR 0.90). Hyperkalemia was more common (RR 2.07), but adverse events remained similar.

  • #cardiology

Like

Save

Share